The mean age of onset for all cases of the locked-in syndrome has generally ranged from 30-50 years. The condition is slightly male predominant. In the ALIS study, amongst men and women who received LIS from vascular and nonvascular agents, both groups were affected equally: 51.2% of men diagnosed vs. 48.1% of women diagnosed.